AJANTPHARM.BOAJANTPHARM.BOBSE
Loading
Gross Profit Growth AcceleratingAccelerating
Percentile Rank64
3Y CAGR+16.1%
5Y CAGR+9.8%
Year-over-Year Change
Year-over-year gross profit growth rate
3Y CAGR
+16.1%/yr
vs +30.7%/yr prior
5Y CAGR
+9.8%/yr
Recent acceleration
Acceleration
-14.6pp
Decelerating
Percentile
P64
Within normal range
vs 5Y Ago
1.6x
Solid growth
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 5.56% |
| Q3 2025 | -34.07% |
| Q2 2025 | 15.76% |
| Q1 2025 | -0.15% |
| Q4 2024 | -3.96% |
| Q3 2024 | 5.46% |
| Q2 2024 | 68.04% |
| Q1 2024 | -35.64% |
| Q4 2023 | 5.01% |
| Q3 2023 | 0.41% |
| Q2 2023 | 20.00% |
| Q1 2023 | -8.76% |
| Q4 2022 | 3.55% |
| Q3 2022 | 1.17% |
| Q2 2022 | 29.03% |
| Q1 2022 | -19.91% |
| Q4 2021 | -0.57% |
| Q3 2021 | 13.23% |
| Q2 2021 | 13.25% |
| Q1 2021 | -12.26% |
| Q4 2020 | 3.48% |
| Q3 2020 | 8.82% |
| Q2 2020 | 16.07% |
| Q1 2020 | -7.95% |
| Q4 2019 | 1.20% |
| Q3 2019 | 1.49% |
| Q2 2019 | 41.95% |
| Q1 2019 | -14.60% |
| Q4 2018 | -13.60% |
| Q3 2018 | 4.99% |
| Q2 2018 | -2.22% |
| Q1 2018 | -8.49% |
| Q4 2017 | 10.60% |
| Q3 2017 | 13.67% |
| Q2 2017 | -1.32% |
| Q1 2017 | -9.88% |
| Q4 2016 | 6.87% |
| Q3 2016 | 7.43% |
| Q2 2016 | 10.90% |
| Q1 2016 | -6.21% |